APOL1-IN-1 structure
|
Common Name | APOL1-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2446817-72-5 | Molecular Weight | 381.40 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H20FN3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of APOL1-IN-1APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD)[1]. |
| Name | APOL1-IN-1 |
|---|
| Description | APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD)[1]. |
|---|---|
| Related Catalog | |
| Target |
Apolipoprotein LI (APOL1)[1] |
| References |
[1]. Brodney M, et, al. Inhibitors of apol1 and methods of using same. WO2020131807A1. |
| Molecular Formula | C21H20FN3O3 |
|---|---|
| Molecular Weight | 381.40 |